KetoSwiss AG

Private

BaselHealthcare & Life Scienceshttps://www.keto.swiss/

Last Round

Seed

Aug 4, 2023

Total Funding Raised

$7.09M

Company Overview

KetoSwiss AG is a biotechnology company that develops medical food products for the dietary management of migraine and related neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Sports & Fitness, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical foodketone bodiesmigraine preventionnutraceuticalsbrain energeticsketogenic dietmetabolic therapydirect-to-consumerD2Cbrain healthnootropicscognitive enhancementbiotech startupbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KetoSwiss AG Comps

Public and private peers based on sector, stage, and business model.

KetoSwiss AG comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

KetoSwiss AG Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Aug 4, 2023
Convertible Debt	Jul 16, 2021
Grant	Jul 1, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Oliver Scherrer

Fractional CFO Head of Finance

Executive Team

KetoSwiss AG Investors

Notable investors and investment history

KetoSwiss AG investors
Investor	Rounds
The William K. Warren Foundation	Seed
Ortho Innovations GmbH	Seed
Swiss National Science Foundation	Grant
Baszucki Group	Seed
Healthspan Capital	Seed
R42 Group	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jul 1, 2021
$650K grant from Swiss National Science Foundation.

View all signals

KetoSwiss AG Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

KetoSwiss AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KetoSwiss AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel

Employee Range9

Year Founded2017

Last FundingAug 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.